Nucleolysin data

BSTC (Lynbrook, N.Y.) said that in an Italian trial required for registration of Nucleolysin in Italy and Switzerland, 76 percent of patients achieved a successful outcome after receiving an injection of the purified enzyme.

Patients entering the study had a diagnosis of herniated intervertebral disc confirmed by CAT scan, MRI and discography, as well as severe back and leg pain that persisted for at least eight weeks and didn't respond to conventional treatment. ...